BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23318441)

  • 1. The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation.
    Kuchenreuther MJ; Weber JD
    Oncogene; 2014 Jan; 33(3):300-7. PubMed ID: 23318441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P19ARF and RasV¹² offer opposing regulation of DHX33 translation to dictate tumor cell fate.
    Zhang Y; Saporita AJ; Weber JD
    Mol Cell Biol; 2013 Apr; 33(8):1594-607. PubMed ID: 23401854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism.
    Oskowitz AZ; Penfornis P; Tucker A; Prockop DJ; Pochampally R
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1563-72. PubMed ID: 21794839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.
    Saporita AJ; Chang HC; Winkeler CL; Apicelli AJ; Kladney RD; Wang J; Townsend RR; Michel LS; Weber JD
    Cancer Res; 2011 Nov; 71(21):6708-17. PubMed ID: 21937682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint.
    Miceli AP; Saporita AJ; Weber JD
    Mol Cell Biol; 2012 Jan; 32(2):348-64. PubMed ID: 22064482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs.
    Fukuda T; Yamagata K; Fujiyama S; Matsumoto T; Koshida I; Yoshimura K; Mihara M; Naitou M; Endoh H; Nakamura T; Akimoto C; Yamamoto Y; Katagiri T; Foulds C; Takezawa S; Kitagawa H; Takeyama K; O'Malley BW; Kato S
    Nat Cell Biol; 2007 May; 9(5):604-11. PubMed ID: 17435748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
    Sebastian T; Johnson PF
    Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
    Takeuchi S; Takahashi A; Motoi N; Yoshimoto S; Tajima T; Yamakoshi K; Hirao A; Yanagi S; Fukami K; Ishikawa Y; Sone S; Hara E; Ohtani N
    Cancer Res; 2010 Nov; 70(22):9381-90. PubMed ID: 21062974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPK.
    Zheng Y; Zhao YD; Gibbons M; Abramova T; Chu PY; Ash JD; Cunningham JM; Skapek SX
    J Biol Chem; 2010 Nov; 285(46):35654-64. PubMed ID: 20826783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex.
    Kawai S; Amano A
    J Cell Biol; 2012 Apr; 197(2):201-8. PubMed ID: 22492723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5.
    Tago K; Funakoshi-Tago M; Itoh H; Furukawa Y; Kikuchi J; Kato T; Suzuki K; Yanagisawa K
    Oncogene; 2015 Jan; 34(3):314-22. PubMed ID: 24469041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of FMRP in Primary MicroRNA Processing via Enhancing Drosha Translation.
    Wan RP; Zhou LT; Yang HX; Zhou YT; Ye SH; Zhao QH; Gao MM; Liao WP; Yi YH; Long YS
    Mol Neurobiol; 2017 May; 54(4):2585-2594. PubMed ID: 26993298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer.
    Salotti J; Sakchaisri K; Tourtellotte WG; Johnson PF
    Mol Cell Biol; 2015 Mar; 35(5):866-83. PubMed ID: 25535333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical microRNAs: individual gene repressors, global translation enhancers.
    Srikantan S; Marasa BS; Becker KG; Gorospe M; Abdelmohsen K
    Cell Cycle; 2011 Mar; 10(5):751-9. PubMed ID: 21311220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I; Murga M; Zubiaga A; Serrano M
    Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells.
    Mudhasani R; Zhu Z; Hutvagner G; Eischen CM; Lyle S; Hall LL; Lawrence JB; Imbalzano AN; Jones SN
    J Cell Biol; 2008 Jun; 181(7):1055-63. PubMed ID: 18591425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.
    Groth A; Weber JD; Willumsen BM; Sherr CJ; Roussel MF
    J Biol Chem; 2000 Sep; 275(35):27473-80. PubMed ID: 10842176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation.
    Kruber P; Angay O; Winkler A; Bösl MR; Kneitz S; Heinze KG; Gessler M
    Int J Cancer; 2019 Mar; 144(6):1391-1400. PubMed ID: 30367465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.